SEC Form 4 · accession 0001214659-15-000050
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sanford S Zweifach
Director
Period of report
Dec 30, 2014
Accepted (ET)
Jan 2, 2015 · 6:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.61 | Dec 30, 2014 | A | 12,500 | A | — | Dec 30, 2024 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in 12 equal monthly installments from the grant date of December 30, 2014. This stock option is fully exercisable on December 30, 2015.